29,056 resources
By Version
By Authority
By Realm
Start Prev Rows 21000 - 21200 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Auth | Source(s) |
---|---|---|---|---|---|---|---|---|---|---|
signal.core.r4 | R4 | episode-of-care-status | EpisodeOfCareStatus | draft | 2 | pa | 2019-10 | us | hl7 | fhir |
signal.core.r4 | R4 | encounter-location-status | EncounterLocationStatus | trial-use | 2 | pa | 2019-10 | us | hl7 | fhir |
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.811 | Observation Result Status (HL7) | active | 2008-01 | us | tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.815 | Result status (HL7) | active | 2008-01 | us | tho | |||
nhsd.assets.stu3 | R3 | ValueSet-eRS-RequestContextStatus-1 | eRS Request Context Status | active | 2018-02 | hl7 | ||||
hl7.fhir.us.physical-activity | R4 | pa-servicerequest-status | PA ServiceRequest Status | informative | pc | 2024-03 | us | hl7 | fhir | |
fhir.argonaut.scheduling | R3 | appt-type | Argonaut Appointment Types | active | 2017-07 | us | hl7 | fhir | ||
hl7.terminology | R5 | variable-role-subtype | EvidenceVariableRoleSubtype | active | 1 | cds | 2024-04 | uv | hl7 | tho |
hl7.terminology | R5 | certainty-subcomponent-type | StatisticCertaintySubcomponentType | draft | 0 | cds | 2020-02 | uv | hl7 | tho |
fhir.cdc.opioid-cds-r4 | R4 | condition-clinical-status-active | Condition Clinical Status Active | active | 2023-05 | us | hl7 | |||
hl7.terminology | R5 | v3-ParticipationSpecimen | ParticipationSpecimen | active | 2014-03 | uv | hl7 | tho | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1039 | Specimen Appropriateness (HL7) | active | 2008-01 | us | tho | |||
hl7.fhir.us.breastcancer | R3 | oncology-BreastSpecimenCollectionMethodVS | BC BreastSpecimenCollectionMethodVS ValueSet | draft | 2018-08 | us | hl7 | sct | ||
hl7.terminology | R5 | v3-RoleLinkHasPart | RoleLinkHasPart | active | 2014-03 | uv | hl7 | tho | ||
hl7.terminology | R5 | v3-ActRelationshipObjective | ActRelationshipObjective | active | 2014-03 | uv | hl7 | tho | ||
hl7.terminology | R5 | v3-ParticipationCoverageTarget | ParticipationCoverageTarget | active | 2014-03 | uv | hl7 | tho | ||
hl7.terminology | R5 | v3-ParticipationGuarantorParty | ParticipationGuarantorParty | active | 2014-03 | uv | hl7 | tho | ||
hl7.fhir.be.terminology | R4 | be-vs-pseudonymization-type | Types of pseudonymization | active | 2024-11 | be | hl7 | |||
hl7.terminology | R5 | v3-LotionDrugForm | LotionDrugForm | active | 2014-03 | uv | hl7 | tho | ||
hl7.terminology | R5 | v3-ManagedParticipationStatusCompleted | ManagedParticipationStatusCompleted | active | 2014-03 | uv | hl7 | tho | ||
hl7.terminology | R5 | v3-ManagedParticipationStatusCancelled | ManagedParticipationStatusCancelled | active | 2014-03 | uv | hl7 | tho | ||
hl7.terminology | R5 | v3-RoleStatusCancelled | RoleStatusCancelled | active | 2014-03 | uv | hl7 | tho | ||
hl7.terminology | R5 | v3-EntityClassCityOrTown | EntityClassCityOrTown | active | 2014-03 | uv | hl7 | tho | ||
hl7.terminology | R5 | v3-EntityClassCountyOrParish | EntityClassCountyOrParish | active | 2014-03 | uv | hl7 | tho | ||
hl7.terminology | R5 | v3-EntityClassCountry | EntityClassCountry | active | 2014-03 | uv | hl7 | tho | ||
hl7.terminology | R5 | v3-EntityClassStateOrProvince | EntityClassStateOrProvince | active | 2014-03 | uv | hl7 | tho | ||
de.gecco | R4 | 1.2.276.0.76.11.541--20200918121718 | Therapeutic Intent | active | sct | |||||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.982 | Directly Observed Therapy (TB) | active | 2008-01 | us | sct tho oid | |||
hl7.fhir.us.davinci-vbpr | R4 | threshold-type | Threshold Type | trial-use | 1 | cqi | 2025-07 | us | hl7 | fhir |
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7983 | Time of Day (Anthrax) | active | 2020-01 | us | sct | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3274 | Timing Prior To Illness Onset | active | 2009-01 | us | oid | |||
ca.healthpei.io.core | R4 | Tradename | active | 2025-06 | ca | sct | ||||
hl7.fhir.us.covid19library | R4 | covid19-pos-neg-vs | Positive, Negative value set | active | 2022-07 | us | hl7 | sct | ||
hl7.fhir.uv.cardx-cied | R5 | cied-monitor-types-vs | CIED Monitor Types | trial-use | 2 | cic | 2025-07 | uv | hl7 | fhir |
hl7.fhir.nz.cca | R4 | cancer-type-code | Cancer type | active | 2020-11 | nz | hl7 | sct | ||
hl7.terminology | R5 | ex-payee-resource-type | ClaimPayeeResourceType | draft | fm | 2020-02 | uv | hl7 | tho | |
hl7.terminology | R5 | plan-definition-type | PlanDefinitionType | active | 2 | cds | 2024-04 | uv | hl7 | tho |
kl.dk.fhir.rehab | R4 | ServiceRequestTypes140 | ServiceRequestTypes | active | 2024-10 | dk | ||||
hl7.terminology | R5 | statistic-type | StatisticStatisticType | active | 5 | fhir | 2024-04 | uv | hl7 | tho |
hl7.terminology | R5 | action-type | ActionType | active | 2 | cds | 2024-04 | uv | hl7 | tho |
ca.on.oh.mha-pds | R4 | organization-referral-source | Organization Referral Source | active | 2022-08 | |||||
ca.on.oh.mha-pds | R4 | outbound-referral-source | Outbound Referral Source | active | 2022-08 | |||||
signal.core.r4 | R4 | address-type | AddressType | normative | 5 | fhir | 2019-10 | us | hl7 | fhir |
hl7.fhir.uv.extensions | R5 | artifact-comment-type | Artifact comment type valueset | trial-use | 2 | cds | 2019-03 | uv | hl7 | fhir |
nhsd.assets.stu3 | R3 | ValueSet-eRS-AttachmentType-1 | eRS Attachment Type | active | 2018-02 | hl7 | ||||
NHSDigital.FHIR.STU3 | R3 | ValueSet-eRS-AttachmentStatus-1 | eRS Attachment Status | active | 2018-02 | hl7 | ||||
hl7.terminology | R5 | v3-ContainerCap | ContainerCap | active | 2014-03 | uv | hl7 | tho | ||
hl7.terminology | R5 | catalogType | CatalogType | active | sd | 2024-04 | uv | hl7 | tho | |
hl7.fhir.uv.cmi | R4 | value-filter-comparator | Value Filter Comparator | active | 2021-08 | uv | hl7 | fhir | ||
hl7.fhir.uv.extensions | R5 | value-filter-comparator | Value Filter Comparator | trial-use | 1 | cds | 2021-08 | uv | hl7 | fhir |
hl7.fhir.uv.cardx-cied | R5 | 11073-10103-DeviceType | IEEE 11073-10103 Device Type | trial-use | 2 | cic | 2025-07 | uv | hl7 | fhir |
de.gecco | R4 | 1.2.276.0.76.11.528--20200701102738 | Discharge Disposition | active | sct | |||||
hl7.terminology | R5 | v3-DocumentSectionType | DocumentSectionType | active | sd | 2014-03 | uv | hl7 | tho loinc | |
hl7-france-fhir.administrative | R4 | fr-email-type | fr-email-type | draft | 0 | fhir | 2021-05 | |||
hl7.fhir.fr.core | R4 | fr-core-vs-email-type | FR Core ValueSet Email type | informative | 0 | fhir | 2024-09 | fr | hl7 | |
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.986 | Encoding Type (HL7) | active | 2008-01 | us | tho | |||
hl7.fhir.ca.baseline | R4 | encountertype | Encounter Type | draft | 2020-07 | ca | hl7 | sct | ||
signal.core.r4 | R4 | us-core-encounter-type | US Core Encounter Type | active | 2022-09 | us | hl7 | sct cpt | ||
hl7.fhir.us.mcode | R4 | mcode-cancer-disease-status-evidence-type-vs | Cancer Disease Status Evidence Type Value Set | active | 3 | cic | 2025-02 | us | hl7 | sct |
hl7.fhir.uv.imaging-service-request-ig | R6 | imagingselection-referencetype | Imaging Selection Reference Type | draft | ii | 2025-03 | uv | hl7 | dcm | |
hl7.fhir.uv.extensions.r4b | R4B | artifactassessment-information-type | Artifact Assessment Information Type | trial-use | 1 | cds | 2020-12 | uv | hl7 | fhir |
hl7.terminology | R5 | library-type | LibraryType | active | 2 | cds | 2024-04 | uv | hl7 | tho |
hl7.terminology | R5 | measure-type | MeasureType | active | 2 | cqi | 2024-04 | uv | hl7 | tho |
hl7.fhir.uv.cow | R4 | order-notification-status-type | Order Notification Status Type | trial-use | 1 | oo | 2025-05 | uv | hl7 | fhir |
hl7.fhir.us.core | R4 | us-core-provenance-participant-type | US Core Provenance Participant Type Codes | trial-use | 3 | cgp | 2022-09 | us | hl7 | fhir tho |
hl7.terminology | R5 | provenance-agent-type | Provenance participant type | active | 1 | fm | 2024-06 | uv | hl7 | tho |
hl7.terminology | R5 | resource-type-link | PayeeResourceType | draft | fm | 2020-02 | uv | hl7 | tho | |
hl7.terminology | R5 | v3-ActInformationAccessCode | ActInformationAccessCode | active | 2014-03 | uv | hl7 | tho | ||
hl7.terminology | R5 | measure-population | MeasurePopulationType | active | 4 | cqi | 2024-04 | uv | hl7 | tho |
hl7.terminology | R5 | audit-event-outcome | Audit Event Outcome | active | 3 | sec | 2010-08 | uv | hl7 | tho |
hl7.terminology | R5 | audit-source-type | Audit Event Source Type | active | 3 | sec | 2010-08 | uv | hl7 | tho |
hl7.terminology | R5 | v3-ActBillingArrangementCode | ActBillingArrangementCode | active | 2014-03 | uv | hl7 | tho | ||
hl7.terminology | R5 | published-in-type | Published In Type | trial-use | 1 | cds | 2025-01 | uv | hl7 | tho |
hl7.fhir.us.codex-radiation-therapy | R4 | codexrt-brachytherapy-device-type-vs | Brachytherapy Device Type Value Set | active | cgp | 2025-02 | us | hl7 | sct | |
hl7.fhir.nz.cca | R4 | sact-regimen-code | Regimen type code | active | 2020-11 | nz | hl7 | |||
signal.core.r4 | R4 | document-relationship-type | DocumentRelationshipType | trial-use | 3 | sd | 2019-10 | us | hl7 | fhir |
hl7.fhir.uv.fhir-for-fair | R4B | related-artifact-type | RelatedArtifactType [ValueSet] | active | 2024-01 | uv | hl7 | fhir | ||
ca.on.oh.mha.pds | R4 | Valueset.ca-on-mha-HousingStatus | Housing Status | draft | 2024-08 | ca | national | sct | ||
hl7.fhir.uv.cardx-cied | R5 | 11073-10103-SessionType | IEEE 11073-10103 Session Type | trial-use | 2 | cic | 2025-07 | uv | hl7 | fhir |
hl7.fhir.us.breastcancer | R3 | oncology-BreastSpecimenTypeVS | BC BreastSpecimenTypeVS ValueSet | draft | 2018-08 | us | hl7 | fhir sct | ||
hl7.terminology | R5 | study-type | StatisticStudyType | draft | 0 | cds | 2020-02 | uv | hl7 | tho |
hl7.fhir.us.pq-cmc-fda | R5 | cmc-product-name-types-vs | Product Name Types Terminology | trial-use | 2 | brr | 2025-07 | us | hl7 | ncit |
niceprofiling.v23q1 | R3 | NICE_PainMeasurementToolCodeList | NICE-PainMeasurementToolCodeList | active | ||||||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7946 | Animal Type (COVID-19) | active | 2020-01 | us | sct tho | |||
hl7.fhir.uv.extensions.r4b | R4B | device-specification-type | Device Specification Type | draft | 1 | oo | uv | hl7 | iso | |
ca.on.oh-seris | R4 | observation-types | Observation Types | draft | ca | sct | ||||
hl7.fhir.uv.extensions.r3 | R3 | performer-function | Performer Function Codes | draft | fhir | 2023-03 | uv | hl7 | tho | |
us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.69.17 | Obligation or Prohibition Instruction Type | active | 2018-01 | us | hl7 | sct | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7130 | Work Schedule (ODH) | active | 2020-01 | us | tho | |||
hl7.terminology | R5 | v3-xEncounterAdmissionUrgency | x_EncounterAdmissionUrgency | active | 2014-03 | uv | hl7 | tho | ||
Test.Training | R3 | CareConnect-NameUse-1 | NameUse | draft | 0 | fhir | 2017-04 | hl7 | fhir | |
NHSDigital.FHIR.STU3 | R3 | CareConnect-NameUse-1 | NameUse | draft | 0 | fhir | 2017-04 | hl7 | fhir | |
ca.on.oh-olis | R4 | name-use | NameUse | normative | 5 | fhir | 2019-10 | hl7 | fhir | |
nhsd.assets.stu3 | R3 | EMS-AddressUse-1 | AddressUse | draft | 0 | fhir | 2017-04 | hl7 | fhir | |
signal.core.r4 | R4 | address-use | AddressUse | normative | 5 | fhir | 2019-10 | us | hl7 | fhir |
ca.healthpei.io.core | R4 | Disease | active | 2025-04 | ca | sct | ||||
hl7-france-fhir.administrative | R4 | identity-method-collection | fr-identity-method-collection | active | 2020-10 | |||||
hl7.fhir.fr.core | R4 | fr-core-vs-identity-method-collection | FR Core ValueSet Identity method collection | active | 2024-09 | fr | hl7 | internal | ||
hl7.fhir.fr.core | R4 | fr-core-vs-mode-validation-identity | FR Core ValueSet Mode validation identity | active | 2024-09 | fr | hl7 | internal | ||
ca.on.oh-seris | R4 | block-release-reason | Block Release Reason | draft | ||||||
ca.on.oh-seris | R4 | block-change-reason | Block Change Reason | draft | ||||||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7382 | Death Reporting Identifier Type (HL70203) (NCHS) | active | 2018-01 | us | tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7122 | Newborn Congenital Anomalies (NCHS) | active | 2013-01 | us | sct | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7423 | Pregnancy Resulting From Fertility Enhancing Drugs | active | 2015-01 | us | sct | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7112 | Fetal Death Time Points (NCHS) | active | 2014-01 | us | sct tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7210 | Apgar Assessments (NCHS) | active | 2015-01 | us | loinc | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7117 | Labor and Delivery Characteristics (NCHS) | active | 2015-01 | us | sct | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7119 | Maternal Morbidities (NCHS) | active | 2015-01 | us | sct | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7135 | Infections During Pregnancy Fetal Death (NCHS) | active | 2017-01 | us | sct tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7113 | Fetal Presentations (NCHS) | active | 2017-01 | us | sct tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7118 | Delivery Routes (NCHS) | active | 2016-01 | us | sct | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7111 | Birth Attendant Titles (NCHS) | active | 2015-01 | us | sct tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7116 | Karyotype Down Syndrome (NCHS) | active | 2013-01 | us | sct | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7115 | Karyotype Suspected Chromosomal Disorder (NCHS) | active | 2013-01 | us | sct | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7163 | Birth and Fetal Death Financial Class (NCHS) | active | 2014-01 | us | ||||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7126 | Pregnancy Risk Factors (NCHS) | active | 2015-01 | us | sct | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7123 | Onset Labor (NCHS) | active | 2013-01 | us | sct | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7121 | Newborn Abnormal Conditions (NCHS) | active | 2015-01 | us | sct oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7124 | Birth or Delivery Occurred (NCHS) | active | 2015-01 | us | sct tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7138 | Histological Placental Examination (NCHS) | active | 2013-01 | us | sct | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7137 | Autopsy Examination (NCHS) | active | 2018-01 | us | sct | |||
us.cdc.phinvads | R4 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.177 | Transfer In (NCHS) | active | 2014-01 | us | oid | |||
us.cdc.phinvads | R4 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.176 | Transferred for Maternal Medical or Fetal Indicat | active | 2015-01 | us | sct | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7164 | Birth and Fetal Death Report Event Reason (NCHS) | active | 2014-01 | us | oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7136 | Obstetric Procedures (NCHS) | active | 2015-01 | us | sct | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7857 | CREI Observation Identifier (NCHS) | active | 2018-12 | us | loinc | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7858 | CCOD Observation Identifier (NCHS) | active | 2018-12 | us | oid loinc | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7853 | MCDI Observation Identifier (NCHS) | active | 2020-01 | us | oid loinc | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7856 | JDI Death Report Observation Identifier (NCHS) | active | 2020-01 | us | oid loinc | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7854 | FDDI Observation Identifier (NCHS) | active | 2021-01 | us | loinc | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7855 | DR Observation Identifier (NCHS) | active | 2020-01 | us | oid loinc | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7208 | Newborn Vital Signs (NCHS) | active | 2015-01 | us | loinc | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7209 | Maternal Vital Signs (NCHS) | active | 2014-01 | us | loinc | |||
lung.ca.screen.assignment | R4 | Lung_cancer_condition | lung-cancer-condition | draft | sct | |||||
ca.on.oh.mha.pds | R4 | gambling-activities-in-last-year | Gambling Activities In Last Year | draft | ca | national | tho | |||
ca.on.oh.mha.pds | R4 | alcohol-anti-craving-medication-enrollment | Alcohol Anti-Craving Medication Enrollment | draft | sct tho | |||||
ca.on.oh.mha.pds | R4 | opioid-agonist-medication-enrollment | Opioid Agonist Medication Enrollment | draft | ca | national | sct tho | |||
ca.on.oh.mha.pds | R4 | gambling-location | Gambling Location | draft | ca | national | ||||
ca.on.oh.mha.pds | R4 | service-termination-continuity | Service Termination Continuity | draft | ca | national | ||||
ca.on.oh.mha.pds | R4 | gambling-problem-identified | Gambling Problem Identified | draft | ca | national | sct tho | |||
ca.on.oh.mha.pds | R4 | alcohol-anti-craving-medication | Alcohol Anti-Craving Medication | draft | sct | |||||
ca.on.oh.mha.pds | R4 | hcn-issuing-authority | HCN Issuing Authority | draft | ca | national | sct tho | |||
ca.on.oh.mha.pds | R4 | sequence-of-gambling-problem | Sequence Of Gambling Problem | draft | ca | national | ||||
ca.on.oh.mha.pds | R4 | gambling-frequency | Gambling Frequency | draft | ca | national | tho | |||
ca.on.oh.mha.pds | R4 | service-modality-type | Service Modality Type | draft | ca | national | ||||
ca.on.oh.mha.pds | R4 | discharge-reason | Discharge Reason | draft | sct | |||||
ca.on.oh.mha.pds | R4 | gambling-help-seeking-reason | Gambling Help Seeking Reason | draft | ca | national | ||||
ca.on.oh.mha.pds | R4 | help-seeking-reason | Help Seeking Reason | draft | ca | national | ||||
ca.on.oh.mha.pds | R4 | gambling-treatment-plan-status | Gambling Treatment Plan Status | draft | ca | national | ||||
ca.on.oh.mha.pds | R4 | transgender-identity | Transgender Identity | draft | ca | national | sct | |||
ca.on.oh.mha.pds | R4 | service-modality-class | Service Modality Class | draft | ca | national | ||||
hl7.fhir.uv.extensions | R5 | parent-relationship-codes | Parent Relationship Codes | trial-use | 3 | pc | 2025-08 | uv | hl7 | tho |
hl7.fhir.uv.extensions | R5 | sibling-relationship-codes | Sibling Relationship Codes | trial-use | 3 | pc | 2025-08 | uv | hl7 | tho |
ca.on.phsd.r4-alpha | R4 | ontario-regions | Ontario Regions | draft | ||||||
ca.on.oh.mha.pds | R4 | income-supporting-code | Income Supporting Code | draft | 2024-08 | ca | national | tho | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.2304 | Organisms (Tests by Microscopic Observation by Giemsa, Wright, or Wright_Giemsa Stain) | active | 2024-06 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.2359 | Organisms (Tests by Microscopic Observation in Unspecified Tissue) | active | 2024-06 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.900 | Organisms (Tests by Microscopic Observation) | active | 2024-06 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.2303 | Organisms (Tests by Microscopic Observation in Blood by Giemsa, Wright, or Wright_Giemsa Stain) | active | 2024-06 | us | hl7 | loinc | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.6055 | Lab Test Name (HEDIS) | active | 2012-01 | us | loinc | |||
signal.core.r4 | R4 | formatcodes | DocumentReference Format Code Set | active | sd | 2019-10 | us | hl7 | ihe | |
us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.90 | D(Rh) Sensitized | active | 2024-06 | us | hl7 | sct | ||
ehealth4u.package | R4 | cyehr-vs-ehdsiallergennodrug | Cyprus EHR Value Set: eHDSI Allergen No Drug | active | sct | |||||
hl7.terminology | R5 | immunization-program-eligibility | Immunization Program Eligibility | active | 1 | pher | 2024-04 | uv | hl7 | tho |
hl7.terminology | R5 | immunization-subpotent-reason | Immunization Subpotent Reason | active | 1 | pher | 2024-04 | uv | hl7 | tho |
hl7.terminology | R5 | immunization-evaluation-dose-status-reason | Immunization Evaluation Dose Status Reason codes | active | 1 | pher | 2024-04 | uv | hl7 | tho |
hl7.terminology | R5 | immunization-funding-source | Immunization Funding Source | active | 1 | pher | 2024-04 | uv | hl7 | tho |
hl7.terminology | R5 | immunization-recommendation-status | Immunization Recommendation Status Codes | active | 1 | pher | 2024-04 | uv | hl7 | tho |
hl7.terminology | R5 | immunization-evaluation-dose-status | Immunization Evaluation Dose Status codes | active | 1 | pher | 2024-04 | uv | hl7 | tho |
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7422 | Fetal Death Cause or Condition (NCHS) | active | 2017-01 | us | sct tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7267 | Death Report Observation Identifier (NCHS) | active | 2018-01 | us | oid loinc | |||
ca.on.oh.erec | R4 | consultation-time | Consultation Time | draft | ||||||
hl7.fhir.us.central-cancer-registry-reporting | R4 | cancer-core-reportability-codes | Cancer Core Reportability Codes | trial-use | 2 | pher | 2021-11 | us | hl7 | sct icd |
hl7.fhir.us.bfdr | R4 | ValueSet-newborn-congenital-anomalies | Newborn Congenital Anomalies | draft | pher | 2025-08 | us | hl7 | sct tho | |
hl7.terminology | R5 | allergyintolerance-verification | AllergyIntolerance Verification Status | active | 3 | pc | 2024-04 | uv | hl7 | tho |
hl7.terminology | R5 | condition-ver-status | ConditionVerificationStatus | active | 3 | pc | 2024-04 | uv | hl7 | tho |
signal.core.r4 | R4 | condition-ver-status | ConditionVerificationStatus | trial-use | 3 | pc | 2019-10 | us | hl7 | tho |
hl7.fhir.uv.cmi | R4 | cql-version | CQL Version | active | 2021-09 | uv | hl7 | fhir | ||
hl7.terminology | R5 | artifact-version-policy | Artifact Version Policy | trial-use | 1 | cds | 2024-02 | uv | hl7 | tho |
hl7-france-fhir.administrative | R4 | identity-validation-mode | fr-mode-validation-identite | active | 2020-01 | |||||
hl7.terminology | R5 | v3-EntityRisk | EntityRisk | active | 2014-03 | uv | hl7 | tho | ||
signal.core.r4 | R4 | composition-status | CompositionStatus | trial-use | 3 | sd | 2019-10 | us | hl7 | fhir |
fhir.cdc.opioid-cds-r4 | R4 | therapies-indicating-end-of-life-care | Therapies indicating end of life care | active | 2023-05 | us | hl7 | sct | ||
de.gecco | R4 | 1.2.276.0.76.11.482--20200503123751 | Respiratory Therapies | active | sct | |||||
dk.fhir.ig.kl.common.caresocial | R4 | KLTheraphyAreasFSIII | KLTheraphyAreasFSIII | active | 2020-10 | |||||
kl.dk.fhir.term | R4 | KLTheraphyAreasFSIII | KLTræningOmråderFSIII | active | 2024-10 | dk | oid | |||
kl.dk.fhir.core | R4 | KLTheraphyAreasFSIII | KLTræningOmråderFSIII | active | 2023-06 | dk | ||||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3272 | Therapy After Illness Onset (Pediatric Flu) | active | 2009-01 | us | sct | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3271 | Therapy Prior Illness Onset (Pediatric Flu) | active | 2009-01 | us | sct oid | |||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.233 | Digital Access Goals | active | 2024-12 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.225 | Digital Literacy Goals | active | 2024-12 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.65 | Elder Abuse Goals | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.30 | Financial Insecurity Goals | active | 2024-06 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.16 | Food Insecurity Goals | active | 2024-06 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.121 | Health Insurance Coverage Status Goals | active | 2024-06 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.117 | Health Literacy Goals | active | 2024-06 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.159 | Homelessness Goals | active | 2024-06 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.161 | Housing Instability Goals | active | 2024-06 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.50 | Inadequate Housing Goals | active | 2024-06 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.257 | Incarceration Status Goals | active | 2024-12 | us | hl7 | vsac |